2023 Q4 Form 10-Q Financial Statement

#000148615923000039 Filed on November 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $964.7M $1.123B $1.189B
YoY Change -5.01% -5.51% 195.7%
Cost Of Revenue $372.3M $531.2M $372.6M
YoY Change 5.77% 42.58% 177.92%
Gross Profit $592.4M $592.2M $816.3M
YoY Change -10.73% -27.45% 204.6%
Gross Profit Margin 61.41% 52.72% 68.66%
Selling, General & Admin $73.06M $78.40M $137.8M
YoY Change -26.77% -43.1% 283.62%
% of Gross Profit 12.33% 13.24% 16.88%
Research & Development $2.073M $1.600M $910.0K
YoY Change 309.68% 75.82% 246.01%
% of Gross Profit 0.35% 0.27% 0.11%
Depreciation & Amortization $167.5M $160.3M $141.0M
YoY Change 18.09% 13.65% 319.5%
% of Gross Profit 28.27% 27.07% 17.28%
Operating Expenses $242.6M $240.3M $279.7M
YoY Change 0.2% -14.1% 300.76%
Operating Profit $349.9M $352.7M $537.3M
YoY Change -17.01% -34.35% 163.92%
Interest Expense $45.50M $7.923M $8.645M
YoY Change -150.27% -8.35% -52.38%
% of Operating Profit 13.01% 2.25% 1.61%
Other Income/Expense, Net $827.0K -$77.97M $403.0M
YoY Change 15.66% -119.35% -435.11%
Pretax Income $389.7M $274.8M $940.3M
YoY Change 16.66% -70.78% 1028.38%
Income Tax $88.05M $65.70M -$1.307M
% Of Pretax Income 22.6% 23.91% -0.14%
Net Earnings $300.5M $209.1M $881.8M
YoY Change -20.4% -76.29% 1125.51%
Net Earnings / Revenue 31.15% 18.61% 74.17%
Basic Earnings Per Share $5.01 $21.34
Diluted Earnings Per Share $6.99 $4.77 $20.45
COMMON SHARES
Basic Shares Outstanding 41.28M shares 41.53M shares 41.45M shares
Diluted Shares Outstanding 43.66M shares 43.11M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $318.0M $265.0M $658.9M
YoY Change -46.39% -59.78% 46.87%
Cash & Equivalents $318.0M $265.0M $658.9M
Short-Term Investments
Other Short-Term Assets $11.06M $595.0K $582.0K
YoY Change -6.73% 2.23% -74.98%
Inventory $72.57M $64.85M $60.96M
Prepaid Expenses $42.45M $20.49M $13.34M
Receivables $943.1M $1.032B $717.1M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.425B $1.420B $1.454B
YoY Change -3.91% -2.34% 93.02%
LONG-TERM ASSETS
Property, Plant & Equipment $5.315B $5.256B $4.656B
YoY Change 12.81% 12.89% 194.16%
Goodwill $0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments $100.2M $102.6M $138.5M
YoY Change -23.28% -25.92%
Other Assets $19.94M $19.55M $22.11M
YoY Change -11.66% -11.55% -75.14%
Total Long-Term Assets $5.502B $5.493B $5.101B
YoY Change 6.86% 7.67% 127.1%
TOTAL ASSETS
Total Short-Term Assets $1.425B $1.420B $1.454B
Total Long-Term Assets $5.502B $5.493B $5.101B
Total Assets $6.926B $6.913B $6.555B
YoY Change 4.45% 5.45% 118.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $34.45M $2.603M $32.71M
YoY Change 18.57% -92.04% 492.34%
Accrued Expenses $493.4M $571.3M $476.6M
YoY Change 36.12% 19.86% 269.49%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $1.165B $1.396B $1.489B
YoY Change -14.39% -6.25% 123.85%
LONG-TERM LIABILITIES
Long-Term Debt $395.9M $395.5M $393.8M
YoY Change 0.43% 0.43% -62.21%
Other Long-Term Liabilities $18.42M $21.02M $29.74M
YoY Change -45.21% -29.32% 270.73%
Total Long-Term Liabilities $414.3M $416.5M $423.5M
YoY Change -3.16% -1.66% -59.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.165B $1.396B $1.489B
Total Long-Term Liabilities $414.3M $416.5M $423.5M
Total Liabilities $1.850B $1.972B $2.084B
YoY Change -5.21% -5.41% 9.35%
SHAREHOLDERS EQUITY
Retained Earnings $1.961B $1.767B $1.226B
YoY Change 35.64% 44.16% 2265.56%
Common Stock $456.0K $448.0K $438.0K
YoY Change -99.99% 2.28% 119.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.077B $4.941B $4.471B
YoY Change
Total Liabilities & Shareholders Equity $6.926B $6.913B $6.555B
YoY Change 4.45% 5.45% 118.54%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income $300.5M $209.1M $881.8M
YoY Change -20.4% -76.29% 1125.51%
Depreciation, Depletion And Amortization $167.5M $160.3M $141.0M
YoY Change 18.09% 13.65% 319.5%
Cash From Operating Activities $543.4M $399.5M $783.6M
YoY Change 13.58% -49.02% 166.2%
INVESTING ACTIVITIES
Capital Expenditures $263.1M $234.8M -$188.8M
YoY Change 15.29% -224.35% 225.63%
Acquisitions
YoY Change
Other Investing Activities -$54.92M -$19.20M $14.80M
YoY Change -57.32% -229.76% -119.02%
Cash From Investing Activities -$318.0M -$254.0M -$174.0M
YoY Change -10.89% 45.96% 28.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -172.3M -95.30M -521.9M
YoY Change -7.98% -81.74% 427.64%
NET CHANGE
Cash From Operating Activities 543.4M 399.5M 783.6M
Cash From Investing Activities -318.0M -254.0M -174.0M
Cash From Financing Activities -172.3M -95.30M -521.9M
Net Change In Cash 53.05M 50.20M 87.74M
YoY Change -180.73% -42.79% 46.99%
FREE CASH FLOW
Cash From Operating Activities $543.4M $399.5M $783.6M
Capital Expenditures $263.1M $234.8M -$188.8M
Free Cash Flow $280.3M $164.7M $972.5M
YoY Change 12.02% -83.06% 175.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
23548000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
200226000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2931956000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2631192000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
489077000 usd
us-gaap Production Tax Expense
ProductionTaxExpense
159473000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
431131000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
227856000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
100775000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
151415000 usd
us-gaap Costs And Expenses
CostsAndExpenses
2005869000 usd
us-gaap Costs And Expenses
CostsAndExpenses
1473829000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
21421000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
38977000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
7923000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
8645000 usd
us-gaap Interest Expense
InterestExpense
22286000 usd
us-gaap Interest Expense
InterestExpense
22810000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9137000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2186000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
19519000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-110413000 usd
us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
949345000 usd
us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
1049545000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
227199000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3352000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
209076000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
941609000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
722146000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1052897000 usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 usd
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-59858000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
425696000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
209076000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
881751000 usd
us-gaap Net Income Loss
NetIncomeLoss
722146000 usd
us-gaap Net Income Loss
NetIncomeLoss
1478593000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
5.01
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
22.79
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
17.28
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
39.28
CY2023Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0
CY2022Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-1.45
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
15.88
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.01
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
21.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
17.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
55.16
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
4.77
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
21.84
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41318000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41670000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26806000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43662000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43107000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43527000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28438000 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4679798000 usd
CY2023Q1 chrd Adjustments To Additional Paid In Capital Warrant Exercised
AdjustmentsToAdditionalPaidInCapitalWarrantExercised
276000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
296999000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4758740000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
15327000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3331000 usd
CY2023Q2 us-gaap Dividends
Dividends
137507000 usd
CY2023Q2 chrd Adjustments To Additional Paid In Capital Warrant Exercised
AdjustmentsToAdditionalPaidInCapitalWarrantExercised
1085000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
216071000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4819570000 usd
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
37.02
CY2023Q3 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#AssetsCurrent
CY2023Q3 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#LiabilitiesCurrent
CY2022Q4 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#AssetsCurrent
CY2022Q4 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#LiabilitiesCurrent
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
3739000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
2595000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
929826000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1159958000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
11247000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-128766000 usd
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
16.54
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
37.02
CY2023Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0
CY2022Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-1.39
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
14.97
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.77
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
20.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
16.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
51.99
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41563000 shares
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
11854000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
10300000 usd
CY2023Q1 us-gaap Dividends
Dividends
204884000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
15003000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10081000 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
192000 usd
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
112504000 usd
CY2023Q3 chrd Adjustments To Additional Paid In Capital Warrant Exercised
AdjustmentsToAdditionalPaidInCapitalWarrantExercised
73357000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
209076000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4941014000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4848000 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4132000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-226000 usd
CY2022Q1 us-gaap Dividends
Dividends
73074000 usd
CY2022Q1 chrd Adjustments To Additional Paid In Capital Warrant Exercised
AdjustmentsToAdditionalPaidInCapitalWarrantExercised
15692000 usd
CY2022Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
191032000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
468314000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1441963000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4815000 usd
CY2022Q2 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
35000 shares
CY2022Q2 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 usd
CY2022Q2 chrd Adjustments To Additional Paid In Capital Warrant Exercised
AdjustmentsToAdditionalPaidInCapitalWarrantExercised
505000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
130839000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1198096000 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2478036000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27402000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
79774000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
30688000 usd
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
31979000 usd
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
124845000 usd
CY2022Q3 chrd Adjustments To Additional Paid In Capital Warrant Exercised
AdjustmentsToAdditionalPaidInCapitalWarrantExercised
2132000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
881751000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4470813000 usd
us-gaap Profit Loss
ProfitLoss
722146000 usd
us-gaap Profit Loss
ProfitLoss
1480904000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
431131000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
227856000 usd
us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
3739000 usd
us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
521495000 usd
us-gaap Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
28964000 usd
us-gaap Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
1073000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
176678000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
66668000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
11247000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-128766000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
21421000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
38977000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
37260000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
40351000 usd
chrd Debt Discount Amortization And Other
DebtDiscountAmortizationAndOther
1072000 usd
chrd Debt Discount Amortization And Other
DebtDiscountAmortizationAndOther
1241000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
258175000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13007000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4945000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2199000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-430000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-7708000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
135880000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
57581000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-42483000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-4766000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1276517000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1445634000 usd
us-gaap Payments To Explore And Develop Oil And Gas Properties
PaymentsToExploreAndDevelopOilAndGasProperties
642584000 usd
us-gaap Payments To Explore And Develop Oil And Gas Properties
PaymentsToExploreAndDevelopOilAndGasProperties
303140000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
361609000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
148363000 usd
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
46002000 usd
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
155728000 usd
chrd Payments For Costs Related To Divestiture Of Businesses
PaymentsForCostsRelatedToDivestitureOfBusinesses
0 usd
chrd Payments For Costs Related To Divestiture Of Businesses
PaymentsForCostsRelatedToDivestitureOfBusinesses
11368000 usd
us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
203238000 usd
us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
487394000 usd
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
40612000 usd
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
428231000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
8499000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
40607000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1112318000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-325699000 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
135000000 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
1035000000 usd
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
135000000 usd
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
1020000000 usd
chrd Payments To Settle Liabilities Assumed
PaymentsToSettleLiabilitiesAssumed
0 usd
chrd Payments To Settle Liabilities Assumed
PaymentsToSettleLiabilitiesAssumed
2154000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
3938000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
157122000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
124845000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
13823000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
36768000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
394652000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
500106000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1398000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
570000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
74611000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
17520000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-492384000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-635861000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-328185000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
484074000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
593151000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
174783000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
264966000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
658857000 usd
chrd Change In Capital Expenditures Incurred But Not Yet Paid
ChangeInCapitalExpendituresIncurredButNotYetPaid
77091000 usd
chrd Change In Capital Expenditures Incurred But Not Yet Paid
ChangeInCapitalExpendituresIncurredButNotYetPaid
41348000 usd
chrd Non Cash Increase Decrease In Asset Retirement Obligations
NonCashIncreaseDecreaseInAssetRetirementObligations
1057000 usd
chrd Non Cash Increase Decrease In Asset Retirement Obligations
NonCashIncreaseDecreaseInAssetRetirementObligations
412000 usd
chrd Noncash Consideration From Acquisition
NoncashConsiderationFromAcquisition
0 usd
chrd Noncash Consideration From Acquisition
NoncashConsiderationFromAcquisition
2585211000 usd
chrd Other Significant Noncash Transaction Value Of Consideration Received Equity Method Investment
OtherSignificantNoncashTransactionValueOfConsiderationReceivedEquityMethodInvestment
0 usd
chrd Other Significant Noncash Transaction Value Of Consideration Received Equity Method Investment
OtherSignificantNoncashTransactionValueOfConsiderationReceivedEquityMethodInvestment
568312000 usd
CY2023Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
36044000 usd
CY2022Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
27256000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1123368000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1188843000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2931956000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2631192000 usd
CY2023Q3 us-gaap Other Inventory Supplies
OtherInventorySupplies
27415000 usd
CY2022Q4 us-gaap Other Inventory Supplies
OtherInventorySupplies
21097000 usd
CY2023Q3 us-gaap Energy Related Inventory Petroleum
EnergyRelatedInventoryPetroleum
37437000 usd
CY2022Q4 us-gaap Energy Related Inventory Petroleum
EnergyRelatedInventoryPetroleum
33314000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
64852000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
54411000 usd
CY2023Q3 chrd Inventory Noncurrent Linefill
InventoryNoncurrentLinefill
22426000 usd
CY2022Q4 chrd Inventory Noncurrent Linefill
InventoryNoncurrentLinefill
22009000 usd
CY2023Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
22426000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
22009000 usd
CY2023Q3 chrd Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
87278000 usd
CY2022Q4 chrd Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
76420000 usd
CY2023Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1041716000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
788893000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10174000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7155000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1031542000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
781738000 usd
CY2023Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
215132000 usd
CY2022Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
127240000 usd
CY2023Q3 chrd Accrued Capital Costs
AccruedCapitalCosts
153838000 usd
CY2022Q4 chrd Accrued Capital Costs
AccruedCapitalCosts
76747000 usd
CY2023Q3 chrd Accrued Lease Operating Expense
AccruedLeaseOperatingExpense
124594000 usd
CY2022Q4 chrd Accrued Lease Operating Expense
AccruedLeaseOperatingExpense
73714000 usd
CY2023Q3 chrd Accrued General And Administrative Expense
AccruedGeneralAndAdministrativeExpense
33170000 usd
CY2022Q4 chrd Accrued General And Administrative Expense
AccruedGeneralAndAdministrativeExpense
42259000 usd
CY2023Q3 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
2285000 usd
CY2022Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
19376000 usd
CY2023Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
19294000 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
5873000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
23005000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
17245000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
571318000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
362454000 usd
CY2023Q3 us-gaap Derivative Credit Risk Valuation Adjustment Derivative Liabilities
DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities
100000 usd
CY2022Q4 us-gaap Derivative Credit Risk Valuation Adjustment Derivative Liabilities
DerivativeCreditRiskValuationAdjustmentDerivativeLiabilities
3500000 usd
chrd Derivative Number Of Instruments Acquired
DerivativeNumberOfInstrumentsAcquired
2 instrument
CY2023Q3 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
91223000 usd
CY2023Q3 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
20837000 usd
CY2023Q3 us-gaap Derivative Assets
DerivativeAssets
70386000 usd
CY2023Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
142560000 usd
CY2023Q3 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
20837000 usd
CY2023Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
121723000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
71114000 usd
CY2022Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
9414000 usd
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
61700000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
353784000 usd
CY2022Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
9414000 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
344370000 usd
CY2023Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
114800000 usd
CY2023Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
300000000 usd
CY2023Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
300000000 usd
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1174756 shares
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
106.25
CY2023Q3 us-gaap Proved Oil And Gas Property Successful Effort Method
ProvedOilAndGasPropertySuccessfulEffortMethod
5890781000 usd
CY2022Q4 us-gaap Proved Oil And Gas Property Successful Effort Method
ProvedOilAndGasPropertySuccessfulEffortMethod
5089185000 usd
CY2023Q3 us-gaap Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization
871997000 usd
CY2022Q4 us-gaap Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization
461175000 usd
CY2023Q3 chrd Proved Oil And Gas Properties Net
ProvedOilAndGasPropertiesNet
5018784000 usd
CY2022Q4 chrd Proved Oil And Gas Properties Net
ProvedOilAndGasPropertiesNet
4628010000 usd
CY2023Q3 us-gaap Unproved Oil And Gas Property Successful Effort Method
UnprovedOilAndGasPropertySuccessfulEffortMethod
206966000 usd
CY2022Q4 us-gaap Unproved Oil And Gas Property Successful Effort Method
UnprovedOilAndGasPropertySuccessfulEffortMethod
30936000 usd
CY2023Q3 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
48605000 usd
CY2022Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
72973000 usd
CY2023Q3 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
18326000 usd
CY2022Q4 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
20576000 usd
CY2023Q3 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
30279000 usd
CY2022Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
52397000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5256029000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4711343000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
13500000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
21400000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
395475000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
394209000 usd
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
165405000 usd
us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
1057000 usd
chrd Asset Retirement Obligation Liabilities Incurred Through Acquisitions
AssetRetirementObligationLiabilitiesIncurredThroughAcquisitions
6771000 usd
us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
3894000 usd
chrd Asset Retirement Obligation Liabilities Settled Through Divestitures
AssetRetirementObligationLiabilitiesSettledThroughDivestitures
32445000 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
8442000 usd
chrd Asset Retirement Obligation Liabilities Held For Sale
AssetRetirementObligationLiabilitiesHeldForSale
-13036000 usd
CY2023Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
132300000 usd
CY2023Q3 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
2300000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.239
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.239
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.003
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.360
CY2023Q3 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
58374000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
3.220
CY2023Q2 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
137507000 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
9.380
us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
400765000 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.250
CY2022Q3 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
70242000 usd
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
18.525
CY2022Q2 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
379369000 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
23.360
us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
522685000 usd
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1023320 shares
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
154.52
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
158100000 usd
chrd Treasury Stock Value Acquired Cost Method Accrued Excise Tax
TreasuryStockValueAcquiredCostMethodAccruedExciseTax
200000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
21.84
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
16.54
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
124800000 usd
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4162883 shares
CY2023Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
209076000 usd
CY2023Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
801000 usd
CY2023Q3 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
208275000 usd
CY2023Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
-28000 usd
CY2023Q3 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
208303000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41563000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
955000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1144000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43662000 shares
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
5.01
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
22.79
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
17.28
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
39.28
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
4.77
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3391000 shares
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
15.88
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
14.97
CY2023Q2 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
55600000 usd
CY2023Q3 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
44000000 usd
CY2022Q3 chrd Common Stock Capital Shares Reserved For Future Distribution
CommonStockCapitalSharesReservedForFutureDistribution
1224840 shares
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
17500000 usd
CY2023Q3 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 usd
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
true

Files In Submission

Name View Source Status
chrd-20230930_cal.xml Edgar Link unprocessable
0001486159-23-000039-index-headers.html Edgar Link pending
0001486159-23-000039-index.html Edgar Link pending
0001486159-23-000039.txt Edgar Link pending
0001486159-23-000039-xbrl.zip Edgar Link pending
chrd-20230930.htm Edgar Link pending
chrd-20230930.xsd Edgar Link pending
chrd-20230930_g1.jpg Edgar Link pending
chrd-ex101x9302023.htm Edgar Link pending
chrd-ex101x9302023001.jpg Edgar Link pending
chrd-ex101x9302023002.jpg Edgar Link pending
chrd-ex101x9302023003.jpg Edgar Link pending
chrd-ex101x9302023004.jpg Edgar Link pending
chrd-ex101x9302023005.jpg Edgar Link pending
chrd-ex101x9302023006.jpg Edgar Link pending
chrd-ex101x9302023007.jpg Edgar Link pending
chrd-ex101x9302023008.jpg Edgar Link pending
chrd-ex101x9302023009.jpg Edgar Link pending
chrd-ex101x9302023010.jpg Edgar Link pending
chrd-ex101x9302023011.jpg Edgar Link pending
chrd-ex101x9302023012.jpg Edgar Link pending
chrd-ex101x9302023013.jpg Edgar Link pending
chrd-ex101x9302023014.jpg Edgar Link pending
chrd-ex101x9302023015.jpg Edgar Link pending
chrd-ex101x9302023016.jpg Edgar Link pending
chrd-ex101x9302023017.jpg Edgar Link pending
chrd-ex101x9302023018.jpg Edgar Link pending
chrd-ex101x9302023019.jpg Edgar Link pending
chrd-ex101x9302023020.jpg Edgar Link pending
chrd-ex101x9302023021.jpg Edgar Link pending
chrd-ex101x9302023022.jpg Edgar Link pending
chrd-ex101x9302023023.jpg Edgar Link pending
chrd-ex101x9302023024.jpg Edgar Link pending
chrd-ex101x9302023025.jpg Edgar Link pending
chrd-ex101x9302023026.jpg Edgar Link pending
chrd-ex101x9302023027.jpg Edgar Link pending
chrd-ex101x9302023028.jpg Edgar Link pending
chrd-ex101x9302023029.jpg Edgar Link pending
chrd-ex101x9302023030.jpg Edgar Link pending
chrd-ex101x9302023031.jpg Edgar Link pending
chrd-ex101x9302023032.jpg Edgar Link pending
chrd-ex101x9302023033.jpg Edgar Link pending
chrd-ex101x9302023034.jpg Edgar Link pending
chrd-ex101x9302023035.jpg Edgar Link pending
chrd-ex101x9302023036.jpg Edgar Link pending
chrd-20230930_pre.xml Edgar Link unprocessable
chrd-20230930_def.xml Edgar Link unprocessable
chrd-20230930_htm.xml Edgar Link completed
chrd-ex101x9302023037.jpg Edgar Link pending
chrd-ex101x9302023038.jpg Edgar Link pending
chrd-ex101x9302023039.jpg Edgar Link pending
chrd-ex101x9302023040.jpg Edgar Link pending
chrd-ex101x9302023041.jpg Edgar Link pending
chrd-ex101x9302023042.jpg Edgar Link pending
chrd-ex101x9302023043.jpg Edgar Link pending
chrd-ex101x9302023044.jpg Edgar Link pending
chrd-ex101x9302023045.jpg Edgar Link pending
chrd-ex101x9302023046.jpg Edgar Link pending
chrd-ex101x9302023047.jpg Edgar Link pending
chrd-ex101x9302023048.jpg Edgar Link pending
chrd-ex101x9302023049.jpg Edgar Link pending
chrd-ex101x9302023050.jpg Edgar Link pending
chrd-ex101x9302023051.jpg Edgar Link pending
chrd-ex101x9302023052.jpg Edgar Link pending
chrd-ex101x9302023053.jpg Edgar Link pending
chrd-ex101x9302023054.jpg Edgar Link pending
chrd-ex101x9302023055.jpg Edgar Link pending
chrd-ex101x9302023056.jpg Edgar Link pending
chrd-ex101x9302023057.jpg Edgar Link pending
chrd-ex101x9302023058.jpg Edgar Link pending
chrd-ex101x9302023059.jpg Edgar Link pending
chrd-ex101x9302023060.jpg Edgar Link pending
chrd-ex101x9302023061.jpg Edgar Link pending
chrd-ex101x9302023062.jpg Edgar Link pending
chrd-ex101x9302023063.jpg Edgar Link pending
chrd-ex101x9302023064.jpg Edgar Link pending
chrd-ex101x9302023065.jpg Edgar Link pending
chrd-ex101x9302023066.jpg Edgar Link pending
chrd-ex101x9302023067.jpg Edgar Link pending
chrd-ex101x9302023068.jpg Edgar Link pending
chrd-ex101x9302023069.jpg Edgar Link pending
chrd-ex101x9302023070.jpg Edgar Link pending
chrd-ex101x9302023071.jpg Edgar Link pending
chrd-ex101x9302023072.jpg Edgar Link pending
chrd-ex101x9302023073.jpg Edgar Link pending
chrd-ex101x9302023074.jpg Edgar Link pending
chrd-ex101x9302023075.jpg Edgar Link pending
chrd-ex101x9302023076.jpg Edgar Link pending
chrd-ex101x9302023077.jpg Edgar Link pending
chrd-ex101x9302023078.jpg Edgar Link pending
chrd-ex101x9302023079.jpg Edgar Link pending
chrd-ex101x9302023080.jpg Edgar Link pending
chrd-ex101x9302023081.jpg Edgar Link pending
chrd-ex101x9302023082.jpg Edgar Link pending
chrd-ex101x9302023083.jpg Edgar Link pending
chrd-ex101x9302023084.jpg Edgar Link pending
chrd-ex101x9302023085.jpg Edgar Link pending
chrd-ex101x9302023086.jpg Edgar Link pending
chrd-ex101x9302023087.jpg Edgar Link pending
chrd-ex101x9302023088.jpg Edgar Link pending
chrd-ex101x9302023089.jpg Edgar Link pending
chrd-ex101x9302023090.jpg Edgar Link pending
chrd-ex101x9302023091.jpg Edgar Link pending
chrd-ex101x9302023092.jpg Edgar Link pending
chrd-ex101x9302023093.jpg Edgar Link pending
chrd-ex101x9302023094.jpg Edgar Link pending
chrd-ex101x9302023095.jpg Edgar Link pending
chrd-ex101x9302023096.jpg Edgar Link pending
chrd-ex101x9302023097.jpg Edgar Link pending
chrd-ex101x9302023098.jpg Edgar Link pending
chrd-ex101x9302023099.jpg Edgar Link pending
chrd-ex101x9302023100.jpg Edgar Link pending
chrd-ex101x9302023101.jpg Edgar Link pending
chrd-ex101x9302023102.jpg Edgar Link pending
chrd-ex101x9302023103.jpg Edgar Link pending
chrd-ex101x9302023104.jpg Edgar Link pending
chrd-ex101x9302023105.jpg Edgar Link pending
chrd-ex101x9302023106.jpg Edgar Link pending
chrd-ex101x9302023107.jpg Edgar Link pending
chrd-ex101x9302023108.jpg Edgar Link pending
chrd-ex101x9302023109.jpg Edgar Link pending
chrd-ex101x9302023110.jpg Edgar Link pending
chrd-ex101x9302023111.jpg Edgar Link pending
chrd-ex101x9302023112.jpg Edgar Link pending
chrd-ex101x9302023113.jpg Edgar Link pending
chrd-ex101x9302023114.jpg Edgar Link pending
chrd-ex101x9302023115.jpg Edgar Link pending
chrd-ex101x9302023116.jpg Edgar Link pending
chrd-ex101x9302023117.jpg Edgar Link pending
chrd-ex101x9302023118.jpg Edgar Link pending
chrd-ex101x9302023119.jpg Edgar Link pending
chrd-ex101x9302023120.jpg Edgar Link pending
chrd-ex101x9302023121.jpg Edgar Link pending
chrd-ex101x9302023122.jpg Edgar Link pending
chrd-ex101x9302023123.jpg Edgar Link pending
chrd-ex101x9302023124.jpg Edgar Link pending
chrd-ex101x9302023125.jpg Edgar Link pending
chrd-ex101x9302023126.jpg Edgar Link pending
chrd-ex101x9302023127.jpg Edgar Link pending
chrd-ex101x9302023128.jpg Edgar Link pending
chrd-ex101x9302023129.jpg Edgar Link pending
chrd-ex101x9302023130.jpg Edgar Link pending
chrd-ex101x9302023131.jpg Edgar Link pending
chrd-ex101x9302023132.jpg Edgar Link pending
chrd-ex101x9302023133.jpg Edgar Link pending
chrd-ex101x9302023134.jpg Edgar Link pending
chrd-ex101x9302023135.jpg Edgar Link pending
chrd-ex101x9302023136.jpg Edgar Link pending
chrd-ex101x9302023137.jpg Edgar Link pending
chrd-ex101x9302023138.jpg Edgar Link pending
chrd-ex101x9302023139.jpg Edgar Link pending
chrd-ex101x9302023140.jpg Edgar Link pending
chrd-ex101x9302023141.jpg Edgar Link pending
chrd-ex101x9302023142.jpg Edgar Link pending
chrd-ex101x9302023143.jpg Edgar Link pending
chrd-ex101x9302023144.jpg Edgar Link pending
chrd-ex101x9302023145.jpg Edgar Link pending
chrd-ex101x9302023146.jpg Edgar Link pending
chrd-ex101x9302023147.jpg Edgar Link pending
chrd-ex101x9302023148.jpg Edgar Link pending
chrd-ex101x9302023149.jpg Edgar Link pending
chrd-ex101x9302023150.jpg Edgar Link pending
chrd-ex101x9302023151.jpg Edgar Link pending
chrd-ex101x9302023152.jpg Edgar Link pending
chrd-ex101x9302023153.jpg Edgar Link pending
chrd-ex101x9302023154.jpg Edgar Link pending
chrd-ex101x9302023155.jpg Edgar Link pending
chrd-ex101x9302023156.jpg Edgar Link pending
chrd-ex101x9302023157.jpg Edgar Link pending
chrd-ex101x9302023158.jpg Edgar Link pending
chrd-ex101x9302023159.jpg Edgar Link pending
chrd-ex101x9302023160.jpg Edgar Link pending
chrd-ex101x9302023161.jpg Edgar Link pending
chrd-ex101x9302023162.jpg Edgar Link pending
chrd-ex101x9302023163.jpg Edgar Link pending
chrd-ex101x9302023164.jpg Edgar Link pending
chrd-ex101x9302023165.jpg Edgar Link pending
chrd-ex101x9302023166.jpg Edgar Link pending
chrd-ex101x9302023167.jpg Edgar Link pending
chrd-ex101x9302023168.jpg Edgar Link pending
chrd-ex101x9302023169.jpg Edgar Link pending
chrd-ex101x9302023170.jpg Edgar Link pending
chrd-ex101x9302023171.jpg Edgar Link pending
chrd-ex101x9302023172.jpg Edgar Link pending
chrd-ex101x9302023173.jpg Edgar Link pending
chrd-ex101x9302023174.jpg Edgar Link pending
chrd-ex101x9302023175.jpg Edgar Link pending
chrd-ex101x9302023176.jpg Edgar Link pending
chrd-ex101x9302023177.jpg Edgar Link pending
chrd-ex101x9302023178.jpg Edgar Link pending
chrd-ex101x9302023179.jpg Edgar Link pending
chrd-ex101x9302023180.jpg Edgar Link pending
chrd-ex101x9302023181.jpg Edgar Link pending
chrd-ex101x9302023182.jpg Edgar Link pending
chrd-ex101x9302023183.jpg Edgar Link pending
chrd-ex101x9302023184.jpg Edgar Link pending
chrd-ex101x9302023185.jpg Edgar Link pending
chrd-ex101x9302023186.jpg Edgar Link pending
chrd-ex101x9302023187.jpg Edgar Link pending
chrd-ex101x9302023188.jpg Edgar Link pending
chrd-ex101x9302023189.jpg Edgar Link pending
chrd-ex101x9302023190.jpg Edgar Link pending
chrd-ex101x9302023191.jpg Edgar Link pending
chrd-ex101x9302023192.jpg Edgar Link pending
chrd-ex101x9302023193.jpg Edgar Link pending
chrd-ex101x9302023194.jpg Edgar Link pending
chrd-ex101x9302023195.jpg Edgar Link pending
chrd-ex101x9302023196.jpg Edgar Link pending
chrd-ex101x9302023197.jpg Edgar Link pending
chrd-ex101x9302023198.jpg Edgar Link pending
chrd-ex101x9302023199.jpg Edgar Link pending
chrd-ex101x9302023200.jpg Edgar Link pending
chrd-ex101x9302023201.jpg Edgar Link pending
chrd-ex101x9302023202.jpg Edgar Link pending
chrd-ex101x9302023203.jpg Edgar Link pending
chrd-ex101x9302023204.jpg Edgar Link pending
chrd-ex101x9302023205.jpg Edgar Link pending
chrd-ex101x9302023206.jpg Edgar Link pending
chrd-ex101x9302023207.jpg Edgar Link pending
chrd-ex101x9302023208.jpg Edgar Link pending
chrd-ex101x9302023209.jpg Edgar Link pending
chrd-ex101x9302023210.jpg Edgar Link pending
chrd-ex101x9302023211.jpg Edgar Link pending
chrd-ex101x9302023212.jpg Edgar Link pending
chrd-ex101x9302023213.jpg Edgar Link pending
chrd-ex101x9302023214.jpg Edgar Link pending
chrd-ex101x9302023215.jpg Edgar Link pending
chrd-ex101x9302023216.jpg Edgar Link pending
chrd-ex101x9302023217.jpg Edgar Link pending
chrd-ex101x9302023218.jpg Edgar Link pending
chrd-ex101x9302023219.jpg Edgar Link pending
chrd-ex101x9302023220.jpg Edgar Link pending
chrd-ex101x9302023221.jpg Edgar Link pending
chrd-ex101x9302023222.jpg Edgar Link pending
chrd-ex101x9302023223.jpg Edgar Link pending
chrd-ex101x9302023224.jpg Edgar Link pending
chrd-ex311x9302023.htm Edgar Link pending
chrd-ex312x9302023.htm Edgar Link pending
chrd-ex321x9302023.htm Edgar Link pending
chrd-ex322x9302023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
chrd-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable